A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus. (Q47374718)
Jump to navigation
Jump to search
scientific article published on 14 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus. |
scientific article published on 14 July 2015 |
Statements
A novel and selective sodium-glucose cotransporter-2 inhibitor, tofogliflozin, improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus (English)
S Ikeda
Y Takano
O Cynshi
R Tanaka
A D Christ
V Boerlin
A Beck
C Ciorciaro
M Meyer
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference